Mange Kevin C, Weir Matthew R
Division of Renal-Electrolyte and Hypertension, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Am J Transplant. 2003 Nov;3(11):1336-40. doi: 10.1046/j.1600-6143.2003.00232.x.
Dialysis has been the long-established initial choice of treatment for persons with end-stage renal disease. Transplantation before dialysis, or preemptive renal transplantation (PRT), has been controversial because of the paucity of clinical evidence that has clarified the benefits vs. risks of this approach. However, several recent observational analyses indicate that PRT is the optimal strategy to benefit patients requiring renal replacement therapy. This current review will discuss the advantages that are associated with PRT, and will summarize studies that have investigated the impact of the timing of transplantation on outcomes. We will also discuss the utility of PRT from various perspectives, and describe the challenges ahead in expanding the opportunity of PRT for more patients.
透析一直是终末期肾病患者长期以来既定的初始治疗选择。透析前移植,即抢先肾移植(PRT),一直存在争议,因为缺乏临床证据来阐明这种方法的利弊。然而,最近的几项观察性分析表明,PRT是使需要肾脏替代治疗的患者受益的最佳策略。本综述将讨论与PRT相关的优势,并总结研究移植时机对预后影响的研究。我们还将从各种角度讨论PRT的效用,并描述在为更多患者扩大PRT机会方面面临的挑战。